Who owns AbCellera Biologics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ABCL from SEC Form 13F filings across 150 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 150 institutions disclosed 116.1M shares of AbCellera Biologics Inc. worth $908.8M — about 38% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
150
13F holders
$908.8M
value, 2026 filers
38%
of shares outstanding (116.1M sh)
41
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ABCL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 33.0M | $259.1M | 1.3% | 10.8% | +9.0% |
| 2 | Capital World Investors | 13.6M | $106.7M | 0.0% | 4.4% | +1.7% |
| 3 | TWO SIGMA INVESTMENTS, LP | 10.4M | $81.9M | 0.1% | 3.4% | -1.2% |
| 4 | TD Waterhouse Canada Inc. | 9.6M | $72.6M | 0.2% | 3.1% | 0.0% |
| 5 | BANK OF AMERICA CORP /DE/ | 6.1M | $48.2M | 0.0% | 2% | +104.7% |
| 6 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 4.3M | $33.9M | 0.0% | 1.4% | -43.0% |
| 7 | ArrowMark Colorado Holdings LLC | 4.1M | $32.2M | 1.3% | 1.3% | 0.0% |
| 8 | BlackRock, Inc. | 3.8M | $29.9M | 0.0% | 1.2% | -5.8% |
| 9 | Driehaus Capital Management LLC | 2.9M | $22.5M | 0.1% | 0.9% | -28.8% |
| 10 | TUDOR INVESTMENT CORP ET AL | 2.1M | $16.2M | 0.0% | 0.7% | -9.3% |
| 11 | MARSHALL WACE, LLP | 1.9M | $14.9M | 0.0% | 0.6% | +428.9% |
| 12 | UBS Group AG | 1.9M | $14.7M | 0.0% | 0.6% | -55.6% |
| 13 | MORGAN STANLEY | 1.7M | $13.1M | 0.0% | 0.5% | -25.0% |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 1.6M | $12.5M | 0.0% | 0.5% | new |
| 15 | CITADEL ADVISORS LLC | 1.6M | $12.5M | 0.0% | 0.5% | +16.6% |
| 16 | NATIONAL BANK OF CANADA /FI/ | 1.2M | $9.7M | 0.0% | 0.4% | +88415.0% |
| 17 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIPNEW | 1.0M | $8.2M | 0.0% | 0.3% | new |
| 18 | RENAISSANCE TECHNOLOGIES LLC | 990,929 | $7.8M | 0.0% | 0.3% | -34.4% |
| 19 | Counterpoint Mutual Funds LLCNEW | 971,643 | $7.6M | 0.8% | 0.3% | new |
| 20 | STATE STREET CORP | 731,362 | $5.7M | 0.0% | 0.2% | +0.2% |
| 21 | HRT FINANCIAL LP | 705,506 | $5.5M | 0.0% | 0.2% | -42.9% |
| 22 | DNB Asset Management ASNEW | 677,479 | $5.3M | 0.0% | 0.2% | new |
| 23 | Guardian Partners Inc. | 595,998 | $4.7M | 0.4% | 0.2% | -66.6% |
| 24 | Intellectus Partners, LLC | 551,583 | $4.3M | 0.7% | 0.2% | +1.0% |
| 25 | Alyeska Investment Group, L.P. | 526,577 | $4.1M | 0.0% | 0.2% | -79.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.